Kondo, U., Kikuchi, T., Sugita, S., Watanabe, M., Matsumoto, C., Nomura-Yogo, M., Kunisada, K., Sawada, H., Sato, K., Takaei, T., Ogura, M., Abe, Y., Hosoya, O., Ishida, T., Tsukada, N. (2025). Baseline cytomegalovirus IgG levels predict reactivation in patients with multiple myeloma receiving elranatamab. Blood. https://doi.org/10.1182/blood-2025-5753